XBiotech Inc.

NASDAQ:XBIT

Biotechnology

Healthcare
$1.68 -0.84%

-$0.02 today

Market cap
$51.22M
Beta
0.84
P/E (TTM)
-1.8
EPS (TTM)
-$1.32
52W Low $2.09High $3.61

Volume 0.05M

Average 0.03M

Balance Sheet

Inspect the capital base behind the business.

Assets

$150.08M

FY 2025 · Annual

-24.6% YoY

Liabilities

$9.73M

FY 2025 · Annual

-42.2% YoY

Equity

$140.35M

FY 2025 · Annual

-23.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents236.98M157.31M200.02M172.68M125.55M
Short-term Investments060.17M000
Net Receivables8.95M1.76M935K858K360K
Inventory00000
Other Current Assets0601K760K1.03M1.04M
Total Current Assets246.87M219.84M201.72M174.57M126.95M
Property, Plant & Equipment (Net)28.31M26.26M24.9M24.53M23.13M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets1.09M1.66M000
Other Non-current Assets(1.09M)(1.66M)000
Total Non-current Assets28.31M26.26M24.9M24.53M23.13M
Total Assets275.18M246.1M226.62M199.09M150.08M
Account Payables2.07M2.41M2.52M2.22M1.54M
Short-term Debt00010.25M0
Tax Payables10K55K83K1.72M76K
Deferred Revenue00000
Other Current Liabilities904K1.17M562K611K5.18M
Total Current Liabilities3.45M4.07M6.1M15.11M7.93M
Long-term Debt00000
Deferred Tax Liabilities873K59K005K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.47M1.58M1.67M1.72M1.8M
Total Non-current Liabilities2.34M1.64M1.67M1.72M1.8M
Total Liabilities5.79M5.7M7.77M16.83M9.73M
Common Stock262.26M267.33M271.15M273.11M276.73M
Retained Earnings5.15M(27.75M)(52.31M)(90.84M)(136.38M)
Accumulated OCI1.97M826K000
Other Stockholders Equity00000
Minority Interest00000
Total Equity269.39M240.4M218.85M182.27M140.35M
Total Debt00010.25M0
Net Debt(236.98M)(157.31M)(200.02M)(162.43M)(125.55M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$115.5M
Receivables$302.0K
Other Current$1.3M
Total Current Assets$117.0M
PP&E (Net)$22.8M
Total Non-current Assets$22.8M
Total Assets$139.8M

Analysis

Selected assets total $139.8M for Latest. The largest visible component is Cash & Equivalents at $115.5M, about 82.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipOct 28, 2026
3Initial statement of beneficial ownershipOct 28, 2026
4Statement of changes in beneficial ownershipOct 28, 2026

How much cash does XBIT have?

XBiotech Inc. (XBIT) reported $125.55M in cash and equivalents in fiscal 2025.

How much debt does XBIT carry?

XBiotech Inc. (XBIT) reported $0.00 of total debt, with net debt of -$125.55M.